Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

4.74
Delayed Data
As of Aug 26
 -0.03 / -0.63%
Today’s Change
4.62
Today|||52-Week Range
11.00
-40.00%
Year-to-Date
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close4.77
Today’s open4.74
Day’s range4.62 - 4.88
Volume2,168,640
Average volume (3 months)1,826,906
Market cap$612.6M
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)+21.93%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.15+1.03%
VNDAVanda Pharmaceutical...+1.16+8.19%
DVAXDynavax Technologies...+0.17+1.06%
CORTCorcept Therapeutics...+0.05+0.92%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs